Review




Structured Review

Sawai Pharmaceutical cjun expression
Cjun Expression, supplied by Sawai Pharmaceutical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cjun expression/product/Sawai Pharmaceutical
Average 90 stars, based on 1 article reviews
cjun expression - by Bioz Stars, 2026-05
90/100 stars

Images



Similar Products

90
Genechem transfection lentivirus vectors expressing sirnas against human cjun
Transfection Lentivirus Vectors Expressing Sirnas Against Human Cjun, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/transfection lentivirus vectors expressing sirnas against human cjun/product/Genechem
Average 90 stars, based on 1 article reviews
transfection lentivirus vectors expressing sirnas against human cjun - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Agilent technologies expression vectors pfa-cjun
Estrogen suppresses RANKL-induced activation of c-Jun and AP-1-mediated transcription in RAW264.7 cells. (A) Cells were treated for the indicated times with RANKL (80 ng/ml) or with the indicated concentrations of RANKL (RL) for 15 min and lysates examined for both JNK1 protein by Western blot and kinase activity (using <t>GST-cJun</t> as substrate). (B) Cells were treated for the indicated times with RANKL (80 ng/ml) and then subjected to Western blot analysis by using antibodies to c-Jun or phospho-c-Jun. Arrows indicate c-Jun and phospho-c-Jun forms. (C) Cells were transfected with a luciferase reporter plasmid (p36) containing three copies of an AP-1 response element. Cells were treated with vehicle or M-CSF and RANKL in the absence or presence of 17β-estradiol (10−8 M). Cells were harvested 24 h later and lysates assessed for luciferase and β-galactosidase activities and protein. Numbers represent the mean ± SE, n = 3 (a is significant vs. b and c; and b is significant vs. c at P ≤ 0.05). The results are representative of three independent experiments. (D) RAW264.7 cells were cotransfected with pFC2-luc and one of the following plasmids: pFA2-cJun (c-Jun), <t>pFA-cFos</t> (c-Fos), pFA-ATF2 (ATF2), or pFC-dbd (Gal4). Following transfection, cells were treated with RANKL in the presence of vehicle, 17β-estradiol (10−8 M), 4-hydroxytamoxifen (10−7 M), or raloxifene (10−7 M). Cells were harvested 24 h later and lysates assessed for luciferase activity, β-galactosidase activity, and protein. Numbers represent the mean ± SE, n = 3 (b is significant vs a and c at P ≤ 0.05). The results are representative of at least three independent experiments.
Expression Vectors Pfa Cjun, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/expression vectors pfa-cjun/product/Agilent technologies
Average 90 stars, based on 1 article reviews
expression vectors pfa-cjun - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Sawai Pharmaceutical cjun expression
Estrogen suppresses RANKL-induced activation of c-Jun and AP-1-mediated transcription in RAW264.7 cells. (A) Cells were treated for the indicated times with RANKL (80 ng/ml) or with the indicated concentrations of RANKL (RL) for 15 min and lysates examined for both JNK1 protein by Western blot and kinase activity (using <t>GST-cJun</t> as substrate). (B) Cells were treated for the indicated times with RANKL (80 ng/ml) and then subjected to Western blot analysis by using antibodies to c-Jun or phospho-c-Jun. Arrows indicate c-Jun and phospho-c-Jun forms. (C) Cells were transfected with a luciferase reporter plasmid (p36) containing three copies of an AP-1 response element. Cells were treated with vehicle or M-CSF and RANKL in the absence or presence of 17β-estradiol (10−8 M). Cells were harvested 24 h later and lysates assessed for luciferase and β-galactosidase activities and protein. Numbers represent the mean ± SE, n = 3 (a is significant vs. b and c; and b is significant vs. c at P ≤ 0.05). The results are representative of three independent experiments. (D) RAW264.7 cells were cotransfected with pFC2-luc and one of the following plasmids: pFA2-cJun (c-Jun), <t>pFA-cFos</t> (c-Fos), pFA-ATF2 (ATF2), or pFC-dbd (Gal4). Following transfection, cells were treated with RANKL in the presence of vehicle, 17β-estradiol (10−8 M), 4-hydroxytamoxifen (10−7 M), or raloxifene (10−7 M). Cells were harvested 24 h later and lysates assessed for luciferase activity, β-galactosidase activity, and protein. Numbers represent the mean ± SE, n = 3 (b is significant vs a and c at P ≤ 0.05). The results are representative of at least three independent experiments.
Cjun Expression, supplied by Sawai Pharmaceutical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cjun expression/product/Sawai Pharmaceutical
Average 90 stars, based on 1 article reviews
cjun expression - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Estrogen suppresses RANKL-induced activation of c-Jun and AP-1-mediated transcription in RAW264.7 cells. (A) Cells were treated for the indicated times with RANKL (80 ng/ml) or with the indicated concentrations of RANKL (RL) for 15 min and lysates examined for both JNK1 protein by Western blot and kinase activity (using GST-cJun as substrate). (B) Cells were treated for the indicated times with RANKL (80 ng/ml) and then subjected to Western blot analysis by using antibodies to c-Jun or phospho-c-Jun. Arrows indicate c-Jun and phospho-c-Jun forms. (C) Cells were transfected with a luciferase reporter plasmid (p36) containing three copies of an AP-1 response element. Cells were treated with vehicle or M-CSF and RANKL in the absence or presence of 17β-estradiol (10−8 M). Cells were harvested 24 h later and lysates assessed for luciferase and β-galactosidase activities and protein. Numbers represent the mean ± SE, n = 3 (a is significant vs. b and c; and b is significant vs. c at P ≤ 0.05). The results are representative of three independent experiments. (D) RAW264.7 cells were cotransfected with pFC2-luc and one of the following plasmids: pFA2-cJun (c-Jun), pFA-cFos (c-Fos), pFA-ATF2 (ATF2), or pFC-dbd (Gal4). Following transfection, cells were treated with RANKL in the presence of vehicle, 17β-estradiol (10−8 M), 4-hydroxytamoxifen (10−7 M), or raloxifene (10−7 M). Cells were harvested 24 h later and lysates assessed for luciferase activity, β-galactosidase activity, and protein. Numbers represent the mean ± SE, n = 3 (b is significant vs a and c at P ≤ 0.05). The results are representative of at least three independent experiments.

Journal:

Article Title: Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression

doi:

Figure Lengend Snippet: Estrogen suppresses RANKL-induced activation of c-Jun and AP-1-mediated transcription in RAW264.7 cells. (A) Cells were treated for the indicated times with RANKL (80 ng/ml) or with the indicated concentrations of RANKL (RL) for 15 min and lysates examined for both JNK1 protein by Western blot and kinase activity (using GST-cJun as substrate). (B) Cells were treated for the indicated times with RANKL (80 ng/ml) and then subjected to Western blot analysis by using antibodies to c-Jun or phospho-c-Jun. Arrows indicate c-Jun and phospho-c-Jun forms. (C) Cells were transfected with a luciferase reporter plasmid (p36) containing three copies of an AP-1 response element. Cells were treated with vehicle or M-CSF and RANKL in the absence or presence of 17β-estradiol (10−8 M). Cells were harvested 24 h later and lysates assessed for luciferase and β-galactosidase activities and protein. Numbers represent the mean ± SE, n = 3 (a is significant vs. b and c; and b is significant vs. c at P ≤ 0.05). The results are representative of three independent experiments. (D) RAW264.7 cells were cotransfected with pFC2-luc and one of the following plasmids: pFA2-cJun (c-Jun), pFA-cFos (c-Fos), pFA-ATF2 (ATF2), or pFC-dbd (Gal4). Following transfection, cells were treated with RANKL in the presence of vehicle, 17β-estradiol (10−8 M), 4-hydroxytamoxifen (10−7 M), or raloxifene (10−7 M). Cells were harvested 24 h later and lysates assessed for luciferase activity, β-galactosidase activity, and protein. Numbers represent the mean ± SE, n = 3 (b is significant vs a and c at P ≤ 0.05). The results are representative of at least three independent experiments.

Article Snippet: The luciferase reporter plasmids pAP1-luc and pFR-luc as well as the expression vectors pFA-cJun, pFA-ATF2, pFA-cFos, and pFC-dbd were obtained from Stratagene. pCMV-βGal was used to normalize for transfection efficiencies.

Techniques: Activation Assay, Western Blot, Activity Assay, Transfection, Luciferase, Plasmid Preparation